Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Aryal, M. R., Gosain, R., Donato, A. A., Pathak, R., Bhatt, V. R., Katel, A., & Kouides, P. A. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01327-9 · Cited by 61

Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis

Bruni, A., Garofalo, E., Zuccalà, V., Currò, G., Torti, C., Navarra, G., Sarro, G. D., Navalesi, P., Longhini, F., & Ammendola, M. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00320-5 · Cited by 61

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Hardy, M. J., Lecompte, T., Douxfils, J., Lessire, S., Dogné, J., Châtelain, B., Testa, S., Gouin‐Thibault, I., Gruel, Y., Medcalf, R. L., et al. (2020) · Thrombosis Journal · doi:10.1186/s12959-020-00230-1 · Cited by 61

Characteristics and outcomes of hospitalised patients with acute kidney injury and COVID-19

Hamilton, P., Hanumapura, P., Castelino, L., Henney, R., Parker, K., Kumar, M., Murphy, M., Al-Sayed, T., Pinnington, S., Felton, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241544 · Cited by 61

Neurological manifestations of coronavirus disease 2019: exploring past to understand present

Desai, I., Manchanda, R., Kumar, N., Tiwari, A., & Kumar, M. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04964-8 · Cited by 62

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation

Salabei, J. K., Fishman, T. J., Asnake, Z. T., Ali, A., & Iyer, U. G. (2021) · Heart & Lung · doi:10.1016/j.hrtlng.2021.01.011 · Cited by 61

The emerging association between COVID-19 and acute stroke

Stein, L. K., Mayman, N. A., Dhamoon, M. S., & Fifi, J. T. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.03.005 · Cited by 62

High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19

Haynes, W. A., Kamath, K., Bozekowski, J. D., Baum, E., Campbell, M., Casanovas‐Massana, A., Daugherty, P. S., Cruz, C. S. D., Dhal, A., Farhadian, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02835-2 · Cited by 60

Coronavirus Disease-2019 (COVID-19) Clinical Features

Kubat, G. O., & Şahin, C. (2020) · kulak burun boğaz ve baş boyun cerrahisi dergisi · doi:10.24179/kbbbbc.2020-75703 · Cited by 60

Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19

Yeo, I., Baek, S., Kim, J. H., Elshakh, H., Voronina, A., Lou, M. S., Vapnik, J., Kaler, R., Dai, X., & Goldbarg, S. H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13241 · Cited by 60

Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases

Taherifard, E., Taherifard, E., Movahed, H., & Mousavi, M. R. (2021) · Hematology · doi:10.1080/16078454.2021.1881225 · Cited by 60

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Ganatra, S., Dani, S. S., Shah, S. P., Asnani, A. H., Neilan, T. G., Lenihan, D. J., Ky, B., Barac, A., Hayek, S. S., Leja, M. J., et al. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.05.004 · Cited by 61

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

Basse, C., Diakite, S., Servois, V., Frélaut, M., Noret, A., Bellesœur, A., Moreau, P., Massiani, M.-A., Bouyer, A.-S., Vuagnat, P., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa090 · Cited by 64

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19

Wang, X., Sahu, K. K., & Černý, J. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02297-z · Cited by 62

COVID-19 and stroke: A review

Qi, X., Keith, K. A., & Huang, J. H. (2020) · Brain Hemorrhages · doi:10.1016/j.hest.2020.11.001 · Cited by 63

Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots

Tung, M. L., Tan, B. W. Q., Cherian, R., & Chandra, B. (2021) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaa081 · Cited by 59

Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy?

Azar, G., Bonnin, S., Vasseur, V., Faure, C., Salviat, F., Vignal‐Clermont, C., Titah, C., Farès, S., Boulanger-Scemama, É., Derrien, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215038 · Cited by 58

How can social media analytics assist authorities in pandemic-related policy decisions? Insights from Australian states and territories

Yiğitcanlar, T., Kankanamge, N., Preston, A., Gill, P. S., Rezayee, M., Ostadnia, M., Xia, B., & Ioppolo, G. (2020) · Health Information Science and Systems · doi:10.1007/s13755-020-00121-9 · Cited by 59

Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19

Quitadamo, P. A., Comegna, L., & Cristalli, P. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.589736 · Cited by 60

Secondary sclerosing cholangitis as a complication of severe COVID‐19: A case report and review of the literature

Klindt, C., Jensen, B. O., Brandenburger, T., Feldt, T., Killer, A., Schimmöller, L., Antoch, G., Senff, T., Hauka, S., Timm, J., et al. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4068 · Cited by 58

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case

Hindilerden, F., Hindilerden, İ. Y., Akar, E., & Yaşar, K. K. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.07.005 · Cited by 57

Role of arachidonic cascade in COVID-19 infection: A review

Ripon, M. A. R., Bhowmik, D. R., Amin, M. T., & Hossain, M. S. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106539 · Cited by 59

Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review

Chen, A., Wang, C., Zhu, W.-L., & Chen, W. (2022) · Aging and Disease · doi:10.14336/ad.2021.0704 · Cited by 60

Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID‐19: Derivation and Validation of the HA 2 T 2 COVID‐19 Mortality Risk Score

Manocha, K. K., Kirzner, J., Ying, X., Yeo, I., Peltzer, B., Ang, B. K., Li, H. A., Lerman, B. B., Safford, M. M., Goyal, P., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018477 · Cited by 56

Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies

Tang, Y., Li, W., Baskota, M., Zhou, Q. X., Fu, Z., Luo, Z., Shi, Y., Chen, Y., & Liu, E. (2021) · Translational Pediatrics · doi:10.21037/tp-20-188 · Cited by 56

Bleeding and Bleeding Risk in COVID-19

Dorgalaleh, A. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1713434 · Cited by 56

COVID-19–Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome

Hutchins, K. L., Jansen, J. H., Comer, A. D., Scheer, R. V., Zahn, G. S., Capps, A. E., Weaver, L., & Koontz, N. A. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6654 · Cited by 55

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections

Kasozi, K. I., Niedbała, G., Alqarni, M. A., Zirintunda, G., Ssempijja, F., Musinguzi, S. P., Usman, I. M., Matama, K., Hetta, ‏. F., Mbiydzenyuy, N. E., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.594458 · Cited by 55

COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?

Favaloro, E. J., Henry, B. M., & Lippi, G. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1728832 · Cited by 55

Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives

Inaba, H., & Aizawa, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708333 · Cited by 58

Letter: Thrombotic Neurovascular Disease in COVID-19 Patients

Sweid, A., Hammoud, B., Weinberg, J., Oneissi, M., Raz, E., Shapiro, M., DePrince, M., Tjoumakaris, S. I., Gooch, M. R., Herial, N. A., et al. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa254 · Cited by 59

Heparin induced thrombocytopenia antibodies in Covid‐19

Patell, R. D., Khan, A. M., Bogue, T., Merrill, M. H., Koshy, A. G., Bindal, P., Joyce, R., Aird, W. C., Neuberg, D. S., Bauer, K. A., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25935 · Cited by 54

Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography

Ferrante, G., Fazzari, F., Cozzi, O., Maurina, M., Bragato, R., D’Orazio, F., Torrisi, C., Lanza, E., Indolfi, E., Donghi, V., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa193 · Cited by 54

COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center

Requena, M., Olivé‐Gadea, M., Muchada, M., García‐Tornel, Á., Deck, M., Juega, J., Boned, S., Rodríguez‐Villatoro, N., Piñana, C., Pagola, J., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105225 · Cited by 54

Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease

Bolaji, P., Kukoyi, B., Ahmad, N., & Wharton, C. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236820 · Cited by 54

Novel Evidence of Acute Kidney Injury in COVID-19

Chueh, T.-I., Zheng, C., Hou, Y., & Lu, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113547 · Cited by 54

Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions

Eser, H. Y., Köroğlu, Y. E., Çakmak, Ö. Ö., Keskin, Ö., Gürsoy, A., & Özdemir, Y. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.656313 · Cited by 55

Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system

Watson, R. A., Johnson, D. M., Dharia, R. N., Merli, G. J., & Doherty, J. U. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1772639 · Cited by 55

SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities

Osuchowski, M. F., Aletti, F. M., Cavaillon, J., Flohé, S. B., Giamarellos‐Bourboulis, E. J., Huber-Lang, M. S., Relja, B., Skirecki, T., Szabó, A., & Maegele, M. (2020) · Shock · doi:10.1097/shk.0000000000001565 · Cited by 50

Neurologic complications of COVID-19

Hassett, C. E., Gedansky, A., Migdady, I., Bhimraj, A., Uchino, K., & Cho, S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc058 · Cited by 55

Pathogenesis‐directed therapy of 2019 novel coronavirus disease

Stratton, C. W., Tang, Y., & Lu, H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26610 · Cited by 59

Cardiovascular disease and COVID-19: les liaisons dangereuses

Barison, A., Aimo, A., Castiglione, V., Arzilli, C., Lupón, J., Codina, P., Santiago‐Vacas, E., Cediel, G., Emdin, M., & Bayés‐Genís, A. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320924501 · Cited by 56

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19

Lega, S., Naviglio, S., Volpi, S., & Tommasini, A. (2020) · Vaccines · doi:10.3390/vaccines8020224 · Cited by 56

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination

Boziki, M. K., Mentis, A. A., Shumilina, M. V., Makshakov, G., Evdoshenko, E. P., & Grigoriadis, N. (2020) · Brain Sciences · doi:10.3390/brainsci10060345 · Cited by 53

Dermatologic manifestations of COVID‐19: a comprehensive systematic review

Mirza, F. N., Malik, A. A., Omer, S. B., & Sethi, A. (2020) · International Journal of Dermatology · doi:10.1111/ijd.15168 · Cited by 52

Psychological and neuropsychiatric implications of COVID-19

Mukaetova-Ladinska, E. B., & Kronenberg, G. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01210-2 · Cited by 54

Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19

Pitt, B., Sutton, N. R., Wang, Z., Goonewardena, S. N., & Holinstat, M. A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173988 · Cited by 52

COVID‐19–related laboratory coagulation findings

Devreese, K. M. J. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13547 · Cited by 52

Cerebrospinal fluid dynamics coupled to the global circulation in holistic setting: Mathematical models, numerical methods and applications

Toro, E. F., Celant, M., Zhang, Q., Contarino, C., Agarwal, N., Linninger, A. A., & Müller, L. O. (2021) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.3532 · Cited by 52

Tissue factor in COVID-19-associated coagulopathy

Subramaniam, S., Kothari, H., & Bosmann, M. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.09.025 · Cited by 53

Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020

Zayet, S., Klopfenstein, T., Kovẚcs, R., Stancescu, S., & Hagenkötter, B. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.201791 · Cited by 51

Implications of COVID-19 in pediatric rheumatology

Batu, E. D., & Özen, S. (2020) · Rheumatology International · doi:10.1007/s00296-020-04612-6 · Cited by 52

Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity

Giavedoni, P., Podlipnik, S., Pericàs, J. M., Fuertes, I., García‐Herrera, A., Alós, L., Carrera, C., Andreu-Febrer, C., Sanz-Beltran, J., Loughlin, C. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103261 · Cited by 51

Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center

Huang, J., Zheng, L., Li, Z., Hao, S., Ye, F., Chen, J., Yao, X., Liao, J., Wang, S., Zeng, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75629-x · Cited by 50

Sex hormones, autoimmunity and gender disparity in COVID-19

Raza, H. A., Sen, P., Bhatti, O. A., & Gupta, L. (2021) · Rheumatology International · doi:10.1007/s00296-021-04873-9 · Cited by 51

Cerebral venous thrombosis in COVID-19

Ghosh, R., Roy, D., Mandal, A., Pal, S. K., Swaika, B. C., Naga, D., Pandit, A., Ray, B. K., & Benito‐León, J. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.04.026 · Cited by 52

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

Godoy, L. C., Goligher, E. C., Lawler, P. R., Slutsky, A. S., & Zarychanski, R. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.201240 · Cited by 52

Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists*

Remy, K. E., Verhoef, P. A., Malone, J. R., Ruppe, M. D., Kaselitz, T. B., Lodeserto, F., Hirshberg, E. L., Slonim, A. D., & Dezfulian, C. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002429 · Cited by 49

Digital Ischemia in COVID-19 Patients: Case Report

Schultz, K., & Wolf, J. M. (2020) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2020.04.024 · Cited by 50

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

Abuo‐Rahma, G. E. A., Mohamed, M. F. A., Ibrahim, T. S., Shoman, M. E., Samir, E., & El-Baky, R. M. A. (2020) · RSC Advances · doi:10.1039/d0ra05821a · Cited by 49

Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series

Vechi, H. T., Maia, L. R., & Alves, M. D. M. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062063 · Cited by 50

Impact of COVID‐19 outbreak on rheumatic patients’ perceptions and behaviors: A cross‐sectional study

Hassen, L. M., AlMaghlouth, I. A., Hassen, I. M., Daghestani, M. H., Almohisen, A., Alqurtas, E. M., Alkhalaf, A., Bedaiwi, M. K., Omair, M. A., Al-Mogairen, S. M., et al. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13959 · Cited by 53

Stroke in Coronavirus Disease 2019: A Systematic Review

Bhatia, R., Pedapati, R., Komakula, S., Srivastava, M. V. P., Vishnubhatla, S., & Khuranac, D. (2020) · Journal of Stroke · doi:10.5853/jos.2020.02264 · Cited by 52

Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Castro, P., Palomo, M., Moreno‐Castaño, A. B., Fernández, S., Torramadé‐Moix, S., Pascual, G., Martínez-Sánchez, J., Richardson, E., Téllez, A., Nicolás, J. M., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07207-w · Cited by 51

The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19

Jevtic, S. D., & Nazy, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.807934 · Cited by 49

Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression

Zhao, R., Su, Z., Komissarov, A. A., Liu, S., Yi, G., Idell, S., Matthay, M. A., & Ji, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691249 · Cited by 50

COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications

Lim, M. S., & McRae, S. J. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103529 · Cited by 50

COVID-19 Guide for the Rehabilitation Clinician

Lopez, M., Bell, K. R., Annaswamy, T. M., Juengst, S. B., & Ifejika, N. L. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001479 · Cited by 51

Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients

Mei, F., Fan, J., Yuan, J., Liang, Z., Wang, K., Sun, J., Guan, W., Huang, M., Yu, L., & Zhang, W. W. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314779 · Cited by 49

Hemostatic Abnormalities in COVID-19: An Update

Aggarwal, M., Dass, J., & Mahapatra, M. (2020) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01328-2 · Cited by 50

Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study

Dalager‐Pedersen, M., Lund, L. C., Mariager, T., Winther, R., Hellfritzsch, M., Larsen, T. B., Thomsen, R. W., Johansen, N. B., Søgaard, O. S., Nielsen, S. L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab003 · Cited by 49

Acute limb ischemia among patients with COVID-19 infection

Galyfos, G. C., Sianou, A., Frountzas, M., Vasilios, K., Vouros, D., Theodoropoulos, C., Michalopoulou, V., Sigala, F., & Filis, K. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.07.222 · Cited by 51

CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients

Spagnolo, P., Cozzi, A., Foà, R., Spinazzola, A., Monfardini, L., Bnà, C., Alì, M., Schiaffino, S., & Sardanelli, F. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-546 · Cited by 49

Clinically significant anticardiolipin antibodies associated with COVID-19

Hossri, S., Shadi, M., Hamarsha, Z., Schneider, R., & ELSAYEGH, D. E. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.05.017 · Cited by 49

Lessons from dermatology about inflammatory responses in Covid‐19

Criado, P. R., Pagliari, C., Carneiro, F. R. O., & Quaresma, J. A. S. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2130 · Cited by 50

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

Talasaz, A. H., Kakavand, H., Tassell, B. W. V., Aghakouchakzadeh, M., Sadeghipour, P., Dunn, S. P., & Geraiely, B. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07037-2 · Cited by 54

Coagulopathy in COVID-19

Galstyan, G. M. (2020) · PULMONOLOGIYA · doi:10.18093/0869-0189-2020-30-5-645-657 · Cited by 49

Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

Talotta, R., & Robertson, E. S. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.05.001 · Cited by 50

Carceral Amplification of COVID-19: Impacts for Community, Corrections Officer, and Incarcerated Population Risks

Lofgren, E., Lum, K., Horowitz, A., Mabubuonwu, B., Myers, K., & Fefferman, N. H. (2022) · Epidemiology · doi:10.1097/ede.0000000000001476 · Cited by 55

Severe autoimmune hemolytic anemia in Covid-19 infection

Hindilerden, F., Hindilerden, İ. Y., Akar, E., Yeşilbağ, Z., & Yaşar, K. K. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.053 · Cited by 48

Screening and testing for COVID ‐19 before surgery

Kovoor, J. G., Tivey, D. R., Williamson, P., Tan, L., Kopunic, H. S., Babidge, W., Collinson, T. G., Hewett, P. J., Hugh, T. J., Padbury, R. T. A., et al. (2020) · ANZ Journal of Surgery · doi:10.1111/ans.16260 · Cited by 49

Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes

de Havenon, A., Yaghi, S. R., Mistry, E. A., Delic, A., Hohmann, S. F., Shippey, E., Stulberg, E. L., Tirschwell, D., Frontera, J. A., Petersen, N., et al. (2020) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2020-016777 · Cited by 48

Elevated glucose level leads to rapid COVID-19 progression and high fatality

Wang, W., Shen, M., Tao, Y., Fairley, C. K., Zhong, Q., Li, Z., Chen, H., Ong, J. J., Zhang, D., Zhang, K., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01413-w · Cited by 48

Persistent Lung Injury and Prothrombotic State in Long COVID

Xiang, M., Jing, H., Wang, C., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862522 · Cited by 52

Estimating the impacts of lockdown on Covid-19 cases in Nigeria

Ajide, K. B., Ibrahim, R. L., & Alimi, O. Y. (2020) · Transportation Research Interdisciplinary Perspectives · doi:10.1016/j.trip.2020.100217 · Cited by 48

High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019

Ferrari, É., Sartre, B., Squara, F., Contenti, J., Occelli, C., Lemoël, F., Levraut, J., Doyen, D., Dellamonica, J., Mondain, V., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017773 · Cited by 48

Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies

Ali, O. H., Bomze, D., Risch, L., Brugger, S. D., Paprotny, M., Weber, M. C., Thiel, S. L., Kern, L., Albrich, W. C., Kohler, P. P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab532 · Cited by 48

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review

Ghasemiyeh, P., Borhani‐Haghighi, A., Karimzadeh, I., Mohammadi‐Samani, S., Vazin, A., Safari, A., & Qureshi, A. I. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s259152 · Cited by 47

Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis

Jin, S., Jin, Y., Bai, X., Hong, J., & Yang, X. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1714369 · Cited by 48

Heparin-Induced Thrombocytopenia in COVID-19

Lingamaneni, P., Gonakoti, S., Moturi, K. R., Vohra, I., & Zia, M. (2020) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709620944091 · Cited by 47

Etiologic Subtypes of Ischemic Stroke in SARS-CoV-2 Patients in a Cohort of New York City Hospitals

Berekashvili, K., Dmytriw, A. A., Vulkanov, V., Agarwal, S., Khaneja, A., Turkel‐Parrella, D., Liff, J. M., Farkas, J., Nandakumar, T., Zhou, T., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01004 · Cited by 47

Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19

Argañaraz, G. A., Palmeira, J. D. F., & Argañaraz, E. R. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00687-7 · Cited by 50

Retinal microvascular signs in COVID-19

Sim, R. Z. H., Cheung, C. M. G., Ting, D. S. W., Wong, E. Y., Wong, T. Y., Yeo, I. Y. S., & Wong, C. W. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-318236 · Cited by 49

COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management

Vajari, M. K., Shirin, M., Pourbagheri‐Sigaroodi, A., Akbari, M. E., Abolghasemi, H., & Bashash, D. (2021) · Cell Biology International · doi:10.1002/cbin.11623 · Cited by 48

Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy

Abdi, A., AlOtaiby, S., Badarin, F. A., Khraibi, A., Hamdan, H., & Nader, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112518 · Cited by 47

Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?

Larson, A. S., Savastano, L. E., Kadirvel, R., Kallmes, D. F., Hassan, A. E., & Brinjikji, W. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016793 · Cited by 46

Behavior of the PR interval with increasing heart rate in patients with COVID-19

Pavri, B. B., Kloo, J., Farzad, D., & Riley, J. M. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.06.009 · Cited by 47

Kidney disease and electrolytes in COVID-19: more than meets the eye

Carriazo, S. M., Kanbay, M., & Ortíz, A. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa112 · Cited by 47

Acute myocardial infarction and large coronary thrombosis in a patient with COVID‐19

Tedeschi, D., Rizzi, A., Biscaglia, S., & Tumscitz, C. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29179 · Cited by 47

Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients

Escalard, S., Chalumeau, V., Escalard, C., Redjem, H., Delvoye, F., Hébert, S., Smajda, S., Cicciò, G., Désilles, J., Mazighi, M., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.031011 · Cited by 46

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2